(en) Karikó K, Buckstein M, Ni H, Weissman D. (2005). Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity23 (2): 165–175. PMID16111635. DOI: 10.1016/j.immuni.2005.06.008.
(2010). Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research38 (17): 5884–92. PMID20457754. PMC2943593. DOI: 10.1093/nar/gkq347.
(2008). Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy16 (11): 1833–40. PMID18797453. PMC2775451. DOI: 10.1038/mt.2008.200.
mrna-conference.com
(en) Katalin Karikó. 8th International mRNA Health Conference. Gearchiveerd op 12 december 2020. Geraadpleegd op 10 januari 2021.
(en) Karikó K, Buckstein M, Ni H, Weissman D. (2005). Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity23 (2): 165–175. PMID16111635. DOI: 10.1016/j.immuni.2005.06.008.
(2010). Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research38 (17): 5884–92. PMID20457754. PMC2943593. DOI: 10.1093/nar/gkq347.
(2008). Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy16 (11): 1833–40. PMID18797453. PMC2775451. DOI: 10.1038/mt.2008.200.